After obtaining patients’ informed consent, genetic analyses and skin biopsies were performed. Genomic DNA was extracted from the peripheral blood of patients of interest using the MagNA Pure Compact System (Roche Diagnostics, Monza, Italy). Targeted mutation analysis was performed by Sanger sequencing. Sequencing was performed in an ABI 3500 genetic analyzer (Applied Biosystems, Foster City, CA, USA) using ABI BigDye 3.1 chemistry, and traces were analyzed with SeqScape software (https://www3.appliedbiosystems.com accessed on 26 January 2023). Total RNA was isolated from skin fibroblasts obtained from punch biopsies in P1 and P2. This was performed using a High Pure RNA Isolation Kit (Roche Diagnostics GmbH, Mannheim, Germany), and the cDNA products were used directly to co-amplify the housekeeping GAPDH and REEP1 transcripts.
Free full text: Click here